Loading organizations...
Birchview Capital, LP is an investment management firm focused on the healthcare sector. It specializes in identifying and supporting entities advancing the biosciences. Its distinct approach integrates rigorous scientific diligence with sophisticated quantitative artificial intelligence and natural language processing, informing investment decisions and enabling navigation of complex scientific landscapes.
The firm was established in 2014 by Matthew W. Strobeck, Ph.D., who serves as its Managing Partner. Dr. Strobeck’s extensive background, including prior ownership of the initial portfolio, underpins the firm’s commitment to deep scientific understanding. This vision for leveraging scientific expertise and technological advancements laid the groundwork for the company’s analytical framework.
Birchview Capital provides discretionary investment management services to privately offered investment funds. Through these, the firm partners with innovative bioscience companies poised for growth. Its long-term vision centers on fostering healthcare advancements by applying a unique blend of scientific rigor and data-driven insights to its investment strategy, contributing to medical discovery.
Birchview Capital has 3 tracked investments across 1 company. The latest tracked deal is $28.0M Series E in Monteris Medical in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 12, 2026 | Monteris Medical | $28.0M Series E | — | CU Healthcare Innovation Fund, Innovahealth Partners, Madryn Asset Management, Mayank Taneja, Robert Lake |
| Oct 28, 2022 | Monteris Medical | $73.0M Debt / Series D Extension | Mortimer Berkowitz, Madryn Asset Management | — |
| Jun 1, 2017 | Monteris Medical | $26.6M Series C | SightLine Partners, Versant Ventures | BDC Capital |
